METHYLPREDNISOLONE HIKMA 500 mg, powder for solution for injection 10 bottles
Active ingredients: Methylprednisolone, Methylprednisolone sodium succinate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for injection10 bottlesintramusculaire;intraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- METHYLPREDNISOLONE HIKMA 500 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 flacons en verre
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62190115CIP73016083CIP133400930160831Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLPREDNISOLONEpoudre | 500 mg · un flacon | FT |
| MÉTHYLPREDNISOLONE SODIQUE (SUCCINATE DE)poudre | 663 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.